disease

FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signaling […]

FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease Read More »

Gene Therapy Notes, , ,

PATHOGEN & HOST FACTORS THAT INFLUENCE DISEASE DEVELOPMENT

Once a disease-causing microorganism (pathogen) gains entry into the body of a susceptible host, the pathogen will adhere or attach itself to specific receptors on the cell surfaces of the host. Upon successful invasion and binding, the microorganism will begin to release chemicals that will eventually attack the host cells. The pathogen (agent) factors includes

PATHOGEN & HOST FACTORS THAT INFLUENCE DISEASE DEVELOPMENT Read More »

Epidemiology, , ,